​

Kailera Therapeutics Ownership | Who Owns Kailera Therapeutics?


OverviewFinancialsChart

Kailera Therapeutics Ownership Summary


Kailera Therapeutics is owned by 98.67% institutional investors, 8.88% insiders. Bain capital investors is the largest institutional shareholder, holding 22.26% of KLRA shares. Vanguard Health Care Inv is the top mutual fund, with 1.69% of its assets in Kailera Therapeutics shares.

KLRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKailera Therapeutics98.67%8.88%-7.55%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bain capital investors26.26M22.26%$578.41M
Bain capital life sciences investors22.58M19.15%$497.51M
Rtw investments, lp10.78M9.14%$237.41M
Canada pension plan investment board7.30M6.19%$160.92M
Atlas venture life science advisors5.17M5.06%$59.06M
Fmr4.66M4.56%$53.22M
Blackrock funding, inc. /de4.57M4.47%$52.22M
Price t rowe associates inc /md/3.53M3.00%$77.86M
Citadel advisors3.24M2.75%$71.39M
Adage capital partners gp3.21M2.72%$70.68M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors22.58M29.58%$497.51M
Royalty pharma sub-manager2.46M14.29%$28.04M
Bain capital investors26.26M12.01%$578.41M
Atlas venture life science advisors5.17M9.36%$59.06M
Rtw investments, lp10.78M2.03%$237.41M
Catalio capital management, lp468.75K1.94%$10.33M
Cormorant asset management, lp550.00K0.62%$12.12M
Siren2.21M0.60%$25.29M
Frazier life sciences management1.10M0.53%$24.23M
Vestal point capital, lp575.00K0.30%$12.67M

Top Buyers

HolderShares% AssetsChange
Bain capital investors26.26M12.01%26.26M
Bain capital life sciences investors22.58M29.58%22.58M
Rtw investments, lp10.78M2.03%10.78M
Canada pension plan investment board7.30M0.09%7.30M
Price t rowe associates inc /md/3.53M0.01%3.53M

Top Sellers

HolderShares% AssetsChange
Eventide asset management---616.72K
Ubs group469.58K0.00%-503.10K
Sixth street partners management company---362.91K
Td asset management---147.70K
Manufacturers life insurance company, the81.81K0.00%-68.01K

New Positions

HolderShares% AssetsChangeValue
Bain capital investors26.26M12.01%26.26M$578.41M
Bain capital life sciences investors22.58M29.58%22.58M$497.51M
Rtw investments, lp10.78M2.03%10.78M$237.41M
Canada pension plan investment board7.30M0.09%7.30M$160.92M
Price t rowe associates inc /md/3.53M0.01%3.53M$77.86M

Sold Out

HolderChange
Fortitude family office-32.00
Persistent asset partners-1.76K
Gabelli funds-10.00K
Hudson bay capital management lp-10.05K
Victory capital management-10.31K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026100-116,376,860-98-100---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv2.19M1.69%2.19M
State Street® SPDR® S&P® Biotech ETF1.31M1.01%34.31K
Vanguard Morn Total Stk Mkt Idx Investor1.18M0.91%-
Vanguard MStar Total Stk Mkt Idx Invest1.18M0.91%-
iShares Russell 2000 ETF1.17M0.90%-
Fidelity Growth Compy Commingled Pl S1.06M0.82%60.40K
Vanguard Small Cap Index835.57K0.64%-17.72K
Columbia Small Cap Growth Inst784.06K0.60%-
Fidelity Growth Company Fund700.90K0.54%-
Columbia Small Cap Growth652.31K0.50%652.31K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 20, 2026RTW INVESTMENTS, LP-Buy$8.00M
Apr 20, 2026BAIN CAPITAL INVESTORS LLC-Buy$134.38M
Apr 20, 2026Koppel Adam Buy$25.00M
Apr 20, 2026Bain Capital Life Sciences Investors, LLC-Buy$25.00M
Apr 20, 2026Kaplan Andrew T. Buy$134.38M

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q25-

KLRA Ownership FAQ


Who Owns Kailera Therapeutics?

Kailera Therapeutics shareholders are primarily institutional investors at 98.67%, followed by 8.88% insiders and -7.55% retail investors. The average institutional ownership in Kailera Therapeutics's industry, Biotech Stocks , is 385.89%, which Kailera Therapeutics falls below.

Who owns the most shares of Kailera Therapeutics?

Kailera Therapeutics’s largest shareholders are Bain capital investors (26.26M shares, 22.26%), Bain capital life sciences investors (22.58M shares, 19.15%), and Rtw investments, lp (10.78M shares, 9.14%). Together, they hold 50.54% of Kailera Therapeutics’s total shares outstanding.

Does Blackrock own Kailera Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kailera Therapeutics.

Who is Kailera Therapeutics’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Kailera Therapeutics’s biggest shareholder by percentage of total assets invested, with 29.58% of its assets in 22.58M Kailera Therapeutics shares, valued at 497.51M$.

Who is the top mutual fund holder of Kailera Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Kailera Therapeutics shares, with 1.69% of its total shares outstanding invested in 2.19M Kailera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools